February 11, 2019 9:35 am
Published by jonas
Redwood Pharma will be attending BIO-Europe 2019 in Vienna, Mar. 25 – 27 to meet and continue discussions with potential... View Article
February 4, 2019 8:00 am
Published by jonas
Redwood Pharma AB (publ) today announces that the first patient has begun testing ofRP101 in a Phase II clinical trial.... View Article
January 7, 2019 9:07 pm
Published by jonas
Redwood Pharma has now also received approval from the German Federal Institute for Drugs and Medical Devices (BfArM) to initiate... View Article
December 14, 2018 8:00 am
Published by jonas
Redwood Pharma has now also received approval from the Austrian Federal Office for Safety in Health Care (BASG / AGES)... View Article
November 12, 2018 11:44 pm
Published by jonas
Redwood Pharma has received its first national approval from the Hungarian National Ministry of Pharmacy regarding the start of the... View Article
October 2, 2018 8:57 am
Published by jonas
The European Patent Office EPO has issued a prior notice of granting a new patent in the portfolio that Redwood... View Article
September 18, 2018 10:19 am
Published by jonas
Redwood Pharma will be attending BIO-Europe 2018 in Copenhagen, Nov. 5 – 7 to meet and continue discussions with potential... View Article
September 10, 2018 10:43 am
Published by jonas
On Tuesday, September 11 Redwood Pharma will participate in the Nordic Life Science Days (NLS) Days conference at the Stockholm... View Article
August 29, 2018 8:49 am
Published by jonas
Redwood Pharma AB (publ) Spotlight Stock Market: REDW redwoodpharma.com The Period January 1 – June 30, 2018 Net Revenues 0... View Article
August 21, 2018 10:16 am
Published by jonas
Redwood Pharma AB (publ), a company which develops medicines in ophthalmology where there is large unmet medical need, announces where... View Article